TRACON Pharmaceuticals Announces Top-line Results from NCI-Sponsored Phase 2 Trial of TRC105 in Recurrent Glioblastoma Pharmaceutical Investing
Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 Pharmaceutical Investing
Diffusion Pharmaceuticals’ TSC Phase 1/2 Glioblastoma Multiforme Clinical Trial Results Published in February 2017 Edition of Journal of Neurosurgery Pharmaceutical Investing
VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac(TM) Phase III Clinical Study Pharmaceutical Investing
Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma Pharmaceutical Investing
Q Biomed Joins With Oklahoma Medical Research Foundation And Rajiv Gandhi Centre For Biotechnology To Develop Liver Cancer Chemotherapeutic Biotech Investing
Immunovaccine's Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial in Ovarian Cancer in Combination With Approved Anti-PD-1 Drug Pharmaceutical Investing
AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda™ Pharmaceutical Investing
